A novel therapeutic molecule against HTLV-1 infection targeting provirus

Leukemia

Volumn 27, Issue 8, 2013, Pages 1621-1627

  Tanaka, A ^a   Takeda, S ^b   Kariya, R ^c   Matsuda, K ^c   Urano, E ^b   Okada, S ^c   Komano, J ^b,d  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

adult T cell leukemia; Human T cell leukemia virus type 1; molecular therapy; zinc finger nuclease

Indexed keywords

ACICLOVIR; ZINC FINGER NUCLEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VIVO STUDY; LONG TERMINAL REPEAT; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ENDONUCLEASES; GENE EXPRESSION; GENE ORDER; GENES, REPORTER; GENETIC VECTORS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROVIRUSES; TERMINAL REPEAT SEQUENCES; TRANSDUCTION, GENETIC; TUMOR BURDEN; ZINC FINGERS;

EID: 84881475632     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.46     Document Type: Article

References (21)

1. Nagai M, Osame M. Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol 2003; 9: 228-235. (Pubitemid 36656456)
2. Watanabe T. HTLV-1-associated diseases. Int J Hematol 1997; 66: 257-278.
3. Yasunaga J, Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 2011; 94: 435-442.
4. Faris M. Potential for molecular targeted therapy for adult T-cell leukemia/lym-phoma. Int Rev Immunol 2008; 27: 71-78. (Pubitemid 351321675)
5. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005; 24: 6047-6057. (Pubitemid 43086122)
6. Carroll D. Progress and prospects: zinc-finger nucleases as gene therapy agents. Gene Ther 2008; 15: 1463-1468.
7. Cannon P, June C. Chemokine receptor 5 knockout strategies. Curr Opin HIV AIDS 2011; 6: 74-79.
8. Handel EM, Cathomen T. Zinc-finger nuclease based genome surgery: it's all about specificity. Curr Gene Ther 2011; 11: 28-37.
9. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL et al. Applications of retrovirus-mediated expression cloning. Exp Hematol 1996; 24: 324-329. (Pubitemid 26093902)
10. Kawakami Y, Miura T, Bissonnette R, Hata D, Khan WN, Kitamura T et al. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 1997; 94: 3938-3942.
11. Komano J, Miyauchi K, Matsuda Z, Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 2004; 15: 5197-5207. (Pubitemid 39564717)
12. Shimizu S, Urano E, Futahashi Y, Miyauchi K, Isogai M, Matsuda Z et al. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex. AIDS 2007; 21: 575-582.
13. Ono A, Hattori S, Kariya R, Iwanaga S, Taura M, Harada H et al. Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice. J Biomed Biotechnol 2011; 2011: 539748.
14. Attia MA, Weiss DW. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 1966; 26: 1787-1800.
15. Harada H, Suzu S, Ito T, Okada S. Selective expansion and engraftment of human CD16 + NK cells in NOD/SCID mice. Eur J Immunol 2005; 35: 3599-3609. (Pubitemid 43025540)
16. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983; 129: 51-64. (Pubitemid 13018139)
17. Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu FT. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am J Pathol 1996; 148: 1661-1670.
18. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawara K, Yoshiki T et al. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines. J Immunol 1985; 135: 3995-4003. (Pubitemid 16250381)
19. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O et al. Establishment of HIV-1 resistance in CD4 + T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26: 808-816. (Pubitemid 351961450)
20. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28: 839-847.
21. Willmore E, de Caux S, Sunter NJ, Tilby MJ, Jackson GH, Austin CA et al. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood 2004; 103: 4659-4665. (Pubitemid 38745999)